HOW CAN WE PREDICT THE DEVELOPMENT OF ANTIBODIES TO INFLIXIMAB IN CROHN’S DISEASE?

Ana Isabel Ferreira  ^{1, 2, 3}     Tiago Lima Capela  ^{1, 2, 3}     Vítor Macedo Silva  ^{1, 2, 3}     Sofia Xavier  ^{1, 2, 3}     Cátia Arieira  ^{1, 2, 3}     Tiago Cúrdia Gonçalves  ^{1, 2, 3}     Francisca Dias de Castro  ^{1, 2, 3}     José Berkeley Cotter  ^{1, 2, 3    
1} Hospital Senhora da Oliveira, Guimarães, Portugal
² School of Medicine, University of Minho, Braga, Portugal
³ PT Government Associate Laboratory, Braga/Guimarãesport, Portugal

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)